Unravelling potential biomarkers for acute and chronic brucellosis through proteomic and bioinformatic approaches.

bioinformatics biomarkers brucellosis differential expression analysis enrichment analysis proteomics random forest model weighted gene co-expression network analysis (WGCNA)

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2023
Historique:
received: 03 05 2023
accepted: 27 06 2023
medline: 1 8 2023
pubmed: 31 7 2023
entrez: 31 7 2023
Statut: epublish

Résumé

This study aimed to identify biomarkers for acute and chronic brucellosis using advanced proteomic and bioinformatic methods. Blood samples from individuals with acute brucellosis, chronic brucellosis, and healthy controls were analyzed. Proteomic techniques and differential expression analysis were used to identify differentially expressed proteins. Co-expression modules associated with brucellosis traits were identified using weighted gene co-expression network analysis (WGCNA). 763 differentially expressed proteins were identified, and two co-expression modules were found to be significantly associated with brucellosis traits. 25 proteins were differentially expressed in all three comparisons, and 20 hub proteins were identified. Nine proteins were found to be both differentially expressed and hub proteins, indicating their potential significance. A random forest model based on these nine proteins showed good classification performance. The identified proteins are involved in processes such as inflammation, coagulation, extracellular matrix regulation, and immune response. They provide insights into potential therapeutic targets and diagnostic biomarkers for brucellosis. This study improves our understanding of brucellosis at the molecular level and paves the way for further research in targeted therapies and diagnostics.

Identifiants

pubmed: 37520434
doi: 10.3389/fcimb.2023.1216176
pmc: PMC10373591
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1216176

Informations de copyright

Copyright © 2023 Yang, Qiao, Yu, Zong, Liu and Li.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Neurol Sci. 2021 Jan 15;420:117280
pubmed: 33358192
Innovation (Camb). 2021 Jul 01;2(3):100141
pubmed: 34557778
J Am Soc Mass Spectrom. 2022 Aug 3;33(8):1530-1540
pubmed: 35816556
Nucleic Acids Res. 2022 Jan 7;50(D1):D1522-D1527
pubmed: 34871441
Comput Biol Med. 2019 Oct;113:103380
pubmed: 31415946
PLoS One. 2022 Jan 13;17(1):e0262551
pubmed: 35025975
PLoS Negl Trop Dis. 2021 Feb 1;15(2):e0009049
pubmed: 33524052
Front Genet. 2023 Mar 13;14:997383
pubmed: 36999049
Front Endocrinol (Lausanne). 2019 Oct 22;10:722
pubmed: 31695682
Immunology. 2015 Jul;145(3):429-42
pubmed: 25752767
J Immunol Res. 2018 May 17;2018:8439813
pubmed: 29888294
Microb Pathog. 2017 Aug;109:239-247
pubmed: 28602839
J Transl Med. 2023 Jun 10;21(1):377
pubmed: 37301958
J Proteome Res. 2021 Dec 3;20(12):5241-5263
pubmed: 34672606
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
J Immunol Res. 2018 Dec 9;2018:1474517
pubmed: 30622973
Saudi J Kidney Dis Transpl. 2021 Jul-Aug;32(4):1171-1175
pubmed: 35229820
Curr Top Med Chem. 2023;23(7):551-578
pubmed: 37073654
Saudi Med J. 2022 May;43(5):522-525
pubmed: 35537721
Methods Mol Biol. 2018;1841:3-10
pubmed: 30259475
Vet Med Sci. 2023 Jan;9(1):523-534
pubmed: 36583994
Nucleic Acids Res. 2019 Jan 8;47(D1):D1211-D1217
pubmed: 30252093
Int J Mol Sci. 2016 Apr 30;17(5):
pubmed: 27144565
J Vet Res. 2022 Dec 18;66(4):559-563
pubmed: 36846044
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Orthop Case Rep. 2021 Mar;11(3):1-5
pubmed: 34239818
Commun Biol. 2023 Jun 10;6(1):628
pubmed: 37301900
Emerg Microbes Infect. 2023 Dec;12(1):2185464
pubmed: 36849445
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
PLoS Comput Biol. 2016 Apr 15;12(4):e1004875
pubmed: 27081850
Trop Doct. 2020 Oct;50(4):360-361
pubmed: 32508259
Clin Microbiol Rev. 2019 Nov 13;33(1):
pubmed: 31722888
Nat Commun. 2023 Mar 18;14(1):1530
pubmed: 36934086

Auteurs

Yuejie Yang (Y)

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin, China.

Kunyan Qiao (K)

Tianjin Institute of Hepatology, Tianjin Second People's Hospital, Tianjin, China.

Youren Yu (Y)

School of Medicine, Nankai University, Tianjin, China.

Yanmei Zong (Y)

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin, China.

Chang Liu (C)

School of Medicine, Nankai University, Tianjin, China.

Ying Li (Y)

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH